ORAL PRESENTATIONS: Friday, 12 April 2019Hepatitis B – drug developmentPS-080-Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold
Hepatitis B – drug development
References (0)
Cited by (0)
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.